Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Lindeman

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Gynecologic Oncology|April 3, 2019
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancerJennifer Taylor Veneris, Elizabeth K Lee, Emily A Goebel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistryMari Mino-Kenudson, Lucian R Chirieac, Kenny Law, et al.
Research Square|January 18, 2024
Wnt inhibition alleviates resistance to immune checkpoint blockade in glioblastomaRakesh Jain, Shanmugarajan Krishnan, Somin Lee, et al.
The American Journal of Surgical Pathology|October 7, 2017
Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital TractJelena Mirkovic, Marie McFarland, Elizabeth Garcia, et al.
Journal of the National Cancer Institute|August 18, 2005
Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutationsToru Mukohara, Jeffrey A Engelman, Nasser H Hanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screeningPasi A Jänne, Ana M Borras, Yanan Kuang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western populationScott J Rodig, Mari Mino-Kenudson, Sanja Dacic, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2025
Wnt inhibition alleviates resistance to anti-PD1 therapy and improves antitumor immunity in glioblastomaShanmugarajan Krishnan, Somin Lee, Zohreh Amoozgar, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 12, 2016
Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq studyStacy W Gray, Elyse R Park, Julie Najita, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 23, 2014
Bio-inspired cryo-ink preserves red blood cell phenotype and function during nanoliter vitrificationRami El Assal, Sinan Guven, Umut Atakan Gurkan, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|April 3, 2019
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancerJennifer Taylor Veneris, Elizabeth K Lee, Emily A Goebel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistryMari Mino-Kenudson, Lucian R Chirieac, Kenny Law, et al.
Research Square|January 18, 2024
Wnt inhibition alleviates resistance to immune checkpoint blockade in glioblastomaRakesh Jain, Shanmugarajan Krishnan, Somin Lee, et al.
The American Journal of Surgical Pathology|October 7, 2017
Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital TractJelena Mirkovic, Marie McFarland, Elizabeth Garcia, et al.
Journal of the National Cancer Institute|August 18, 2005
Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutationsToru Mukohara, Jeffrey A Engelman, Nasser H Hanna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
A rapid and sensitive enzymatic method for epidermal growth factor receptor mutation screeningPasi A Jänne, Ana M Borras, Yanan Kuang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western populationScott J Rodig, Mari Mino-Kenudson, Sanja Dacic, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2025
Wnt inhibition alleviates resistance to anti-PD1 therapy and improves antitumor immunity in glioblastomaShanmugarajan Krishnan, Somin Lee, Zohreh Amoozgar, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 12, 2016
Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq studyStacy W Gray, Elyse R Park, Julie Najita, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 23, 2014
Bio-inspired cryo-ink preserves red blood cell phenotype and function during nanoliter vitrificationRami El Assal, Sinan Guven, Umut Atakan Gurkan, et al.
Pageof 7